The development and stability assessment of extemporaneous pediatric formulations of Accupril.
Freed A.L, Silbering S.B, Kolodsick K.J, Rossi D, Mahjour M, Kingsmill C.A. (carol.kingsmill@pfizer.com )
Int J Pharm - 2005 - 304; 1-2: 135-144.